Metabolic flexibility refers to the ability of tissues to adapt their use of energy sources
according to substrate availability and energy demands. This review aims to disentangle the …

Aim To develop an evidence-based expert group opinion on the role of insulin motivation to
overcome insulin distress during different stages of insulin therapy and to propose a …

The prevalence of type 2 diabetes mellitus has been increasing worldwide. As the
therapeutic options for type 2 diabetes mellitus have evolved over the last 2 decades …

Objective The American Diabetes Association and the European Association for the Study of
Diabetes guidelines recommend to individualize treatment targets/strategies in inadequately …

Atherosclerosis is a chronic inflammatory disease. A growing body of evidence suggests that
the metabolic syndrome is major risk factor for the disease and a predictor of cardiovascular …

Introduction Real-world evidence on insulin glargine 100 U/ml (Gla-100) initiation in Indian
type 2 diabetes mellitus (T2DM) individuals is limited. The present study aimed to evaluate …

Liraglutide (victoza, Novo Nordisk A/S) is human GLP-1 analogue developed by
recombinant DNA technology. It is indicated along with diet and exercise in management of …

Nonalcoholic fatty liver disease (NAFLD) has long been associated with metabolic
syndrome, because of the high prevalence of obesity, dyslipidemia, diabetes, hypertension …

Within a few years following the discovery of insulin, hypoglycemia emerged as an important
side effect. It remains a major barrier, preventing many with diabetes from reaching glucose …

Background: In India, glimepiride has become a promising option for add-on therapy with
metformin in patients with type-2 diabetes mellitus (T2DM) owing to its efficacy, safety, and …